Grading dermatologic adverse events of cancer treatments: The common terminology criteria for adverse events version 4.0.
Journal of the American Academy of Dermatology.
Times cited: 79
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group.
Supportive Care in Cancer.
Times cited: 85
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment.
Seminars in Radiation Oncology.
Times cited: 1549